You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 25, 2024

TIOPRONIN - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic sources for tiopronin and what is the scope of patent protection?

Tiopronin is the generic ingredient in three branded drugs marketed by Mission Pharmacal, Amneal, Endo Operations, Teva Pharms Inc, Torrent, Mission Pharma, and Teva Pharms Usa Inc, and is included in eight NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are three drug master file entries for tiopronin. Six suppliers are listed for this compound.

Summary for TIOPRONIN
US Patents:1
Tradenames:3
Applicants:7
NDAs:8
Drug Master File Entries: 3
Finished Product Suppliers / Packagers: 6
Raw Ingredient (Bulk) Api Vendors: 105
Clinical Trials: 5
Patent Applications: 2,494
What excipients (inactive ingredients) are in TIOPRONIN?TIOPRONIN excipients list
DailyMed Link:TIOPRONIN at DailyMed
Recent Clinical Trials for TIOPRONIN

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
NYU Langone HealthPhase 2
New York University School of MedicinePhase 2
Revive Therapeutics, Ltd.Phase 2

See all TIOPRONIN clinical trials

Pharmacology for TIOPRONIN
Anatomical Therapeutic Chemical (ATC) Classes for TIOPRONIN
Paragraph IV (Patent) Challenges for TIOPRONIN
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
THIOLA EC Delayed-release Tablets tiopronin 300 mg 211843 1 2022-10-11

US Patents and Regulatory Information for TIOPRONIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Endo Operations TIOPRONIN tiopronin TABLET, DELAYED RELEASE;ORAL 217219-001 Feb 24, 2023 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Mission Pharmacal THIOLA EC tiopronin TABLET, DELAYED RELEASE;ORAL 211843-001 Jun 28, 2019 AB RX Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Mission Pharmacal THIOLA EC tiopronin TABLET, DELAYED RELEASE;ORAL 211843-002 Jun 28, 2019 AB RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Torrent TIOPRONIN tiopronin TABLET, DELAYED RELEASE;ORAL 216990-001 Jan 30, 2024 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Torrent TIOPRONIN tiopronin TABLET, DELAYED RELEASE;ORAL 216990-002 Jan 30, 2024 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Teva Pharms Inc TIOPRONIN tiopronin TABLET, DELAYED RELEASE;ORAL 216456-001 Jul 22, 2024 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.